New TB vaccines could save 7 million lives by 2050

GAVI projects that next-generation tuberculosis vaccines, expected from 2029, could prevent an estimated 7.3 million deaths and generate up to US$135 billion in economic benefits for low- and middle-income countries by 2050. The forecast implies substantial potential returns on vaccine procurement and delivery investment, though realizing them depends on advance planning to secure sufficient supply for high-burden countries. For African health systems and manufacturers, the timeline creates both a market opportunity and pressure to strengthen distribution and financing capacity before rollout.